Jack Galbraith, MD
Family Medicine · Saint Louis, MONPI 1649373440
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 85.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $893 and has fallen 62.3% since, to $336 in 2024.
Across 134 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$161
- Lilly USA, LLC$108
- Pfizer$54
- Abbott$39
- AstraZeneca$33
- plus $31 from 2 others
What the payments were for
- Food & beverage$2,895100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 108 | $2,481 |
| Novo Nordisk | 11 | $161 |
| Lilly USA, LLC | 6 | $108 |
| Pfizer | 3 | $54 |
| Abbott | 2 | $39 |
| AstraZeneca | 2 | $33 |
| GSK | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$2,906 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 73 | $92,857 |
| MounjaroTirzepatide | 68 | $73,899 |
| EliquisApixaban | 70 | $67,131 |
| OzempicSemaglutide | 54 | $63,929 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $37,853 |
| TrulicityDulaglutide | 17 | $29,716 |
| XareltoRivaroxaban | 26 | $29,018 |
| FarxigaDapagliflozin Propanediol | 17 | $20,711 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $6,963 |
| Atorvastatin Calcium | 512 | $6,293 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $6,198 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 22 | $5,047 |
| Semglee (Yfgn) PenInsulin Glargine-Yfgn | 30 | $4,941 |
| Levothyroxine Sodium | 327 | $4,610 |
| Omeprazole | 264 | $4,126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $108 | $103,61585 claims |
| PfizerEliquis, Abrysvo | $54 | $71,05384 claims |
| Novo NordiskOzempic | $161 | $63,92954 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Arnuity Ellipta | $18 | $51,27081 claims |
| AstraZenecaFarxiga | $33 | $20,71117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Saint Louis
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- David GlickSaint Louis$17K
- Aaron BjornSaint Louis$16K
- Paul RutledgeSaint Louis$16K
- Melissa MurraySaint Louis$15K
- Robert PozziSaint Louis$15K
- Amy MillerSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.